Abstract
Introduction: Increasing numbers of women are established on antiplatelets medications at conception or during pregnancy, however, little evidence exists to inform management including intrapartum use of regional anaesthesia (RA), beyond aspirin. We aimed to systematically review contemporary data on the safety of clopidogrel and newer antiplatelet agents in pregnant women, with particular attention to RA.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
